Literature DB >> 19845694

Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals.

J Rodríguez-Baño1, M D López-Prieto, M M Portillo, P Retamar, C Natera, E Nuño, M Herrero, A del Arco, A Muñoz, F Téllez, M Torres-Tortosa, A Martín-Aspas, A Arroyo, A Ruiz, R Moya, J E Corzo, L León, J A Pérez-López.   

Abstract

Classification of bloodstream infections (BSIs) as community-acquired (CA), healthcare-associated (HCA) and hospital-acquired (HA) has been proposed. The epidemiology and clinical features of BSI according to that classification in tertiary-care (TH) and community (CH) hospitals were investigated in a prospective cohort of 821 BSI episodes from 15 hospitals (ten TH and five CH hospitals) in Andalucía, Spain. Eighteen percent were CA, 24% were HCA and 58% were HA. The incidence of CA and HCA BSI was higher in CH than in TH (CA: 3.9 episodes per 1000 admissions vs. 2.2, p <0.01; HCA: 5.0 vs. 2.9, p <0.01), whereas the incidence of HA BSI was lower (7.7 vs. 8.7, p <0.01). In CA and HCA BSI, the respiratory tract was more frequently the source in CH than in TH (CA: 30% vs. 15%; HCA: 20% vs. 9%, p ≤0.03). In HCA BSI, chronic renal insufficiency and tunnelled catheters were less frequent in CH than in TH (11% vs. 26% and 7% vs. 19%, p ≤0.03), although chronic ulcers were more frequent (22% vs. 8%, p 0.008). BSIs as a result of methicillin-resistant Staphylococcus aureus or Pseudomonas aeruginosa were very rare in CA episodes, although extended-spectrum b-lactamase-producing Escherichia coli (ESBLEC) caused a similar proportion of all BSIs in CA, HCA and HA episodes. Multivariate analysis revealed no significant difference in mortality rates in CH and TH. HCA infections should be considered as a separate class of BSI in both TH and CH, although differences between hospitals must be considered. CA BSIs were not caused by multidrug-resistant pathogens, except for ESBLEC.
© 2010 The Authors. Journal Compilation © 2010 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Year:  2010        PMID: 19845694     DOI: 10.1111/j.1469-0691.2009.03089.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  42 in total

1.  Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis.

Authors:  Pilar Retamar; María M Portillo; María Dolores López-Prieto; Fernando Rodríguez-López; Marina de Cueto; María V García; María J Gómez; Alfonso Del Arco; Angel Muñoz; Antonio Sánchez-Porto; Manuel Torres-Tortosa; Andrés Martín-Aspas; Ascensión Arroyo; Carolina García-Figueras; Federico Acosta; Juan E Corzo; Laura León-Ruiz; Trinidad Escobar-Lara; Jesús Rodríguez-Baño
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

2.  Community-onset bacteraemia of unknown origin: clinical characteristics, epidemiology and outcome.

Authors:  C Hernandez; N Cobos-Trigueros; C Feher; L Morata; C De La Calle; F Marco; M Almela; A Soriano; J Mensa; A Del Rio; J A Martinez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-08       Impact factor: 3.267

3.  Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.

Authors:  Jesús Rodríguez-Baño; Encarnación Picón; Paloma Gijón; José Ramón Hernández; Jose M Cisneros; Carmen Peña; Manuel Almela; Benito Almirante; Fabio Grill; Javier Colomina; Sonia Molinos; Antonio Oliver; Carlos Fernández-Mazarrasa; Gemma Navarro; Ana Coloma; Lorena López-Cerero; Alvaro Pascual
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

4.  Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance.

Authors:  F Docobo-Pérez; G L Drusano; A Johnson; J Goodwin; S Whalley; V Ramos-Martín; M Ballestero-Tellez; J M Rodriguez-Martinez; M C Conejo; M van Guilder; J Rodríguez-Baño; A Pascual; W W Hope
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

5.  Distinct cell death programs in monocytes regulate innate responses following challenge with common causes of invasive bacterial disease.

Authors:  Steve J Webster; Marc Daigneault; Martin A Bewley; Julie A Preston; Helen M Marriott; Sarah R Walmsley; Robert C Read; Moira K B Whyte; David H Dockrell
Journal:  J Immunol       Date:  2010-07-23       Impact factor: 5.422

6.  Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria.

Authors:  Joshua T Thaden; Lawrence P Park; Stacey A Maskarinec; Felicia Ruffin; Vance G Fowler; David van Duin
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

7.  Audit of aspects of practice in relation to patients with suspected community-onset blood stream infection.

Authors:  M A Reza; M Cormican
Journal:  Ir J Med Sci       Date:  2017-03-02       Impact factor: 1.568

Review 8.  Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned.

Authors:  David van Duin; David L Paterson
Journal:  Infect Dis Clin North Am       Date:  2016-06       Impact factor: 5.982

9.  The outcome and timing of death of 17,767 nosocomial bloodstream infections in acute care hospitals in Finland during 1999-2014.

Authors:  Keiju S K Kontula; Kirsi Skogberg; Jukka Ollgren; Asko Järvinen; Outi Lyytikäinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-02-17       Impact factor: 3.267

10.  Nosocomial urinary tract infections caused by extended-spectrum beta-lactamase uropathogens: Prevalence, pathogens, risk factors, and strategies for infection control.

Authors:  Khaireddine Bouassida; Mehdi Jaidane; Olfa Bouallegue; Ghassen Tlili; Habiba Naija; Ali Tahar Mosbah
Journal:  Can Urol Assoc J       Date:  2016 Mar-Apr       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.